EGFR and ERBB2 exon 20 insertion/duplication in advanced non–small cell lung cancer: genomic profiling and clinicopathologic features

BACKGROUND: Exon 20 (ex20) in-frame insertions or duplications (ins/dup) in epidermal growth factor receptor (EGFR) and its analog erb-b2 receptor tyrosine kinase 2 (ERBB2) are each detected in 1.5% of non–small cell lung cancer (NSCLC). Unlike EGFR p.L858R or ex19 deletions, ex20 ins/dup is associa...

Descripción completa

Detalles Bibliográficos
Autores principales: Sompallae, Ramakrishna R., Dundar, Bilge, Guseva, Natalya V., Bossler, Aaron D., Ma, Deqin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10239961/
https://www.ncbi.nlm.nih.gov/pubmed/37284196
http://dx.doi.org/10.3389/fonc.2023.1163485

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10239961/
https://www.ncbi.nlm.nih.gov/pubmed/37284196
http://dx.doi.org/10.3389/fonc.2023.1163485

Ejemplares similares